Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
about
Update on the hyper immunoglobulin M syndromesAutosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation.Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kindNF-κB in the regulation of epithelial homeostasis and inflammation.Hypohidrotic ectodermal dysplasia and immunodeficiency with coincident NEMO and EDA mutations.Toll-like receptor signaling in primary immune deficiencies.NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions.ICON: the early diagnosis of congenital immunodeficiencies.Inflammatory bowel disease caused by primary immunodeficiencies-Clinical presentations, review of literature, and proposal of a rational diagnostic algorithm.Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG / NEMO mutations.Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency.Disseminated BCG infection mimicking metastatic nasopharyngeal carcinoma in an immunodeficient child with a novel hypomorphic NEMO mutation.Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency.A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy.Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.Successful hematopoietic cell transplantation in patients with unique NF-κB essential modulator (NEMO) mutations.Necroptosis in development and diseases.
P2860
Q28972255-FD056495-F928-48D2-A777-97063C0D714EQ33409176-6F573D8D-435D-4B36-B093-7BE8B8875073Q35090141-ED855AEB-A9C3-48AE-8484-321E0ABD59F5Q35190461-95B49EAA-65CD-4C02-87F2-488F191112ECQ35347805-49C07A20-29CA-476D-96CB-AD30FC555547Q35927447-816BF07B-58F6-4EAF-B603-9608CDE3B45BQ36238886-FC2E5206-4C3A-486D-98DA-A40AB7694776Q36718219-DB7BF3FF-EE56-4D36-AD39-FB0712562F3CQ38195246-FEF1CF93-641D-4584-A993-581133457F57Q39312948-E9F111F6-1489-4FC9-A900-1194EC464A1EQ40146597-B8BDA0E3-114F-40DF-979E-C100610D2F27Q40166610-CBBE251E-E9D7-4D08-88F1-108CFCEC8B6DQ40318502-2C26D418-0342-49FD-B901-D308ADC9706CQ40817291-E8DEBAAE-E5B9-4E71-A4F6-59C3547EC434Q45345436-2777B76A-1479-449A-BEAE-E23C69AB0E4DQ51851019-2C7E3D92-C232-420B-A6F4-08ED973FAACFQ54334567-D518D6D5-D2D7-44E0-9E8E-CF690C368E6EQ54981573-3A71BBDE-E254-460A-A26E-6650C9FFC6C0
P2860
Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Challenges in the use of allog ...... plasia with immune deficiency.
@en
Challenges in the use of allog ...... plasia with immune deficiency.
@nl
type
label
Challenges in the use of allog ...... plasia with immune deficiency.
@en
Challenges in the use of allog ...... plasia with immune deficiency.
@nl
prefLabel
Challenges in the use of allog ...... plasia with immune deficiency.
@en
Challenges in the use of allog ...... plasia with immune deficiency.
@nl
P2093
P2860
P356
P1476
Challenges in the use of allog ...... plasia with immune deficiency.
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2008.308
P407
P577
2008-09-15T00:00:00Z